P3 Health Partners Analyst Ratings
P3 Health Partners Analyst Ratings
While ratings are subjective and will change, the latest P3 Health Partners (PIII) rating was a initiated with a price target of $0.00 to $5.00. The current price P3 Health Partners (PIII) is trading at is $1.98, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/01/2023 | 152.53% | BTIG | → $5 | Initiates Coverage On | → Buy |
| 06/30/2023 | — | TD Cowen | Initiates Coverage On | → Market Perform | |
| 01/04/2022 | — | William Blair | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 09/01/2023 | 152.53% | BTIG | →$5 | 开始承保 | →购买 |
| 2023/06/30 | - | TD Cowen | 开始承保 | →市场表现 | |
| 01/04/2022 | - | 威廉·布莱尔 | 开始承保 | →跑赢大盘 |
What is the target price for P3 Health Partners (PIII)?
P3 Health Partners(PIII)的目标价格是多少？
The latest price target for P3 Health Partners (NASDAQ: PIII) was reported by BTIG on September 1, 2023. The analyst firm set a price target for $5.00 expecting PIII to rise to within 12 months (a possible 152.53% upside). 2 analyst firms have reported ratings in the last year.
BTIG于2023年9月1日报道了P3健康合作伙伴(纳斯达克：PIII)的最新目标价。这家分析公司将目标价定为5美元，预计PIII将在12个月内上涨至(可能上涨152.53%)。去年有两家分析公司公布了评级。
What is the most recent analyst rating for P3 Health Partners (PIII)?
P3 Health Partners(PIII)的最新分析师评级是多少？
The latest analyst rating for P3 Health Partners (NASDAQ: PIII) was provided by BTIG, and P3 Health Partners initiated their buy rating.
纳斯达克对P3健康伙伴(BTIG：PIII)的最新分析师评级是由毕马威提供的，P3健康伙伴发起了买入评级。
When is the next analyst rating going to be posted or updated for P3 Health Partners (PIII)?
P3 Health Partners(PIII)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of P3 Health Partners, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for P3 Health Partners was filed on September 1, 2023 so you should expect the next rating to be made available sometime around September 1, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与P3 Health Partners的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。P3 Health Partners的上一次评级是在2023年9月1日提交的，因此您应该预计下一次评级将在2024年9月1日左右提供。
Is the Analyst Rating P3 Health Partners (PIII) correct?
分析师对P3 Health Partners(PIII)的评级正确吗？
While ratings are subjective and will change, the latest P3 Health Partners (PIII) rating was a initiated with a price target of $0.00 to $5.00. The current price P3 Health Partners (PIII) is trading at is $1.98, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的P3健康伙伴(PIII)评级是以0.00美元至5.00美元的目标价启动的。P3 Health Partners(PIII)目前的交易价格为1.98美元，在分析师的预测范围内。
